搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 6 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Highlights From Fuorisalone At Milan Design Week 2024
Forbes· 1 日前At the primary fair, Salone del Mobile, leading global brands present their newest collections, ...
Artificial Sweetener Could Seriously Damage Gut, According To New Study
Forbes· 3 日前"There is now growing awareness of the health impacts of sweeteners such as saccharin, sucralose and aspartame, with our ...
30 Great Biographies To Bury Yourself In
Forbes· 2 日前Biographies offer a chance to explore the decision-making and circumstances around some of ...
General Motors results beat targets, forecast raised, shares jump
Reuters· 5 日前, opens new tab on Tuesday posted quarterly results that topped Wall Street targets and the ...
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
CNBC· 4 日前Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its ...
Ticks claim the life of a middle-aged woman in mainland China
Dimsum Daily· 2 日前26th April 2024 – (Nanjing) A woman in her 50s from Jiangsu, mainland China, recently passed away after experiencing fever ...
Scott Dixon stretches fuel to inch closer to A.J. Foyt on IndyCar's all-time win list
Bastillepost· 7 日前Scott Dixon used mind-boggling fuel-saving strategy Sunday to win the Grand Prix of Long Beach and move closer to A.J. Foyt ...